Skip to main content
Vita 34 AG logo

Vita 34 AG — Investor Relations & Filings

Ticker · V3V ISIN · DE000A0BL849 LEI · 529900OEWA4GSZEZ4P40 F Human health and social work activities
Filings indexed 794 across all filing types
Latest filing 2011-07-11 Report Publication Anno…
Country DE Germany
Listing F V3V

About Vita 34 AG

https://www.vita34.de/en/

Vita 34 AG is a biobank specializing in the cryopreservation of stem cells derived from umbilical cord blood and tissue. Established in 1997 as the first private cord blood bank in Europe, the company offers services for the long-term storage of perinatal stem cells for potential future medical applications. The service portfolio includes providing collection kits for childbirth, handling logistics, processing the biological material, and storing the stem cell deposits under cryogenic conditions. These services are offered to expectant parents as a form of private medical provision for their child and family. As part of the Famicord Group, Vita 34 is also involved in research and development related to cell-based therapies.

Recent filings

Filing Released Lang Actions
Report Publication Announcement 2011
Report Publication Announcement Classification · 100% confidence The document is a short announcement dated July 11, 2011, stating that the 'Financial report of the group (half-year)' will be disclosed on July 18, 2011, and provides direct links to the German and English versions of that report. According to the 'MENU VS MEAL' rule, a short document announcing the publication of a report, rather than containing the full report content, should be classified as a Report Publication Announcement (RPA). The content explicitly states the report is forthcoming and provides links, fitting the RPA definition perfectly.
2011-07-11 English
Hinweis auf Halbjahresfinanzbericht vom 01.01.2011 bis zum 30.06.2011
Report Publication Announcement Classification · 100% confidence The document is a short notification (873 characters) that explicitly states the availability of a half-year financial report via a URL. It does not contain the financial report itself, but rather serves as an announcement of its publication. According to the 'Menu vs Meal' rule, this is classified as a Report Publication Announcement (RPA).
2011-07-11 German
Datum:11.07.2011
Report Publication Announcement Classification · 100% confidence The document is a short notification (858 characters) informing stakeholders that the semi-annual financial report for the period 01.01.2011 to 30.06.2011 is available for download via a provided URL. Following the 'Menu vs Meal' rule, since this is an announcement of a report's availability rather than the report itself, it is classified as a Report Publication Announcement (RPA).
2011-07-11 German
VITA 34 International AG: VITA 34 International AG expands to Slovakia
Regulatory Filings Classification · 100% confidence The document is a short news release dated June 22, 2011, announcing that VITA 34 International AG has expanded its business by founding a wholly-owned subsidiary in Slovakia. It discusses market strategy and operational plans, but it is not a formal financial report (like 10-K or IR), an earnings release (ER), or a management discussion (MDA). It is a general corporate announcement regarding business expansion. Since it doesn't fit the specific categories like M&A (TAR), Capital Change (CAP), or Director Dealing (DIRS), and it is a standard corporate news item disseminated via DGAP, the most appropriate general category is Regulatory Filings (RNS), which serves as the fallback for miscellaneous regulatory announcements that don't fit elsewhere, especially when disseminated through official channels like DGAP.
2011-06-22 English
Audit Report / Information 2011
Audit Report / Information Classification · 95% confidence The document is titled "AKTIONÄRSBRIEF 1/2011" (Shareholder Letter 1/2011). It contains updates on company activities (BioCube construction, mobile stem cell team), medical case studies using stored cord blood, ESG/responsibility statements, donation activities, and a summary of 2010 financial goals achieved, along with Q1 2011 revenue figures. It also mentions the full Annual Report and Q1 Report are available for download. This format—a letter to shareholders summarizing operational, medical, and financial highlights for a period, often including responsibility sections—is characteristic of an Investor Relations communication that is not a formal regulatory filing like a 10-K or a standalone Earnings Release (ER). Since it provides a comprehensive overview of the period's activities and financial performance summary, it aligns best with an Investor Presentation (IP) or a general Investor Report/Letter. Given the structure and content focusing on operational achievements, research, and financial context, 'Investor Presentation' (IP) is the most fitting category, as it serves as a detailed update for investors beyond a simple press release. Q1 2011
2011-06-16 German
VITA 34 International AG: Bekanntmachung der Einberufung zur Hauptversammlung am 12.07.2011 in Leipzig mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information Classification · 100% confidence The document is explicitly titled 'Einladung zur ordentlichen Hauptversammlung' (Invitation to the Annual General Meeting) and details the agenda (Tagesordnung) for a meeting scheduled for July 12, 2011. The agenda items include the presentation of the 2010 annual financial statements, voting on the discharge of the Board and Supervisory Board, appointment of auditors, and crucially, resolutions regarding a merger (Verschmelzungsvertrag) and changes to the company's articles of association (Satzungsänderung). This content is characteristic of materials prepared for and presented at an Annual General Meeting (AGM). Therefore, the classification is AGM-R.
2011-06-01 German

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.